Skip to main content

Larynx Cancer

  • Chapter
  • First Online:
Target Volume Delineation and Field Setup

Part of the book series: Practical Guides in Radiation Oncology ((PGRO))

  • 667 Accesses

Abstract

Radiotherapy plays an integral role in the management of laryngeal cancers of all stages. Hypofractionated radiotherapy offers excellent results for early-stage squamous cell carcinomas of the glottic larynx. Definitive chemoradiotherapy is a standard of care for advanced larynx cancers that are amenable to organ preservation therapy. For high-risk cases after surgery, postoperative radiotherapy or chemoradiotherapy can reduce the risk of locoregional recurrence. Physical exam, including laryngoscopy, is an essential part of pre-treatment evaluation and is critical for the assessment of the airway, fixation of the vocal cords, and target delineation. Imaging, including thin-cut CTs of the larynx, PET/CT, and MRI, may help in identifying lymph node metastases, paraglottic extension, and subglottic extension. This chapter discusses general principles of target delineation for a variety of common clinical scenarios. Detailed, slice-by-slice cases are shown for early-stage disease, organ preservation in advanced disease, and postoperative radiotherapy after total laryngectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Chera BS, Amdur RJ, Morris CG, Mendenhall WM. Carotid-sparing intensity-modulated radiotherapy for early-stage squamous cell carcinoma of the true vocal cord. Int J Radiat Oncol Biol Phys. 2010;77(5):1380–5.

    Article  Google Scholar 

  2. Gomez D, Cahlon O, Mechalakos J, Lee N. An investigation of intensity-modulated radiation therapy versus conventional two-dimensional and 3D-conformal radiation therapy for early stage larynx cancer. Radiat Oncol. 2010;5:74.

    Article  Google Scholar 

  3. Rosenthal DI, Fuller CD, Barker JL Jr, et al. Simple carotid-sparing intensity-modulated radiotherapy technique and preliminary experience for T1–2 glottic cancer. Int J Radiat Oncol Biol Phys. 2010;77(2):455–61.

    Article  Google Scholar 

  4. Yamazaki H, Nishiyama K, Tanaka E, et al. Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Oncol Biol Phys. 2006;64:77–82.

    Article  Google Scholar 

  5. Le QT, Fu KK, Kroll S, et al. Influence of fraction size, total dose, and overall time on local control of T1–T2 glottic carcinoma. Int J Radiat Oncol Biol Phys. 1997;39(1):115–26.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nancy Y. Lee .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Fan, D., Kang, J.J., Yu, Y., Cahlon, O., Riaz, N., Lee, N.Y. (2022). Larynx Cancer. In: Lee, N.Y., Lu, J.J., Yu, Y. (eds) Target Volume Delineation and Field Setup. Practical Guides in Radiation Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-99590-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-99590-4_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-99589-8

  • Online ISBN: 978-3-030-99590-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics